Significant Ownership of Rosalind Advisors, Inc.

Signature - Title
Steven Salamon - President
Location
Toronto
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Rosalind Advisors, Inc..

Notify me when Rosalind Advisors, Inc. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Rosalind Advisors, Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DCTH DELCATH SYSTEMS, INC. DELCATH SYSTEMS, INC. 9.9% $70,022,327 +$468,900 6,719,993 +0.67% Rosalind Advisors, Inc. 31 Dec 2025
PYPD PolyPid Ltd. Common Shares 9.9% $25,443,176 -$1,030,600 5,483,443 -3.9% Rosalind Advisors, Inc. 31 Dec 2025
TLPH TALPHERA, INC. Common Shares 9.9% $13,545,483 -$830,679 13,150,954 -5.8% Rosalind Advisors, Inc. 31 Dec 2025
BFRI Biofrontera Inc. Common Shares 9.9% $11,817,810 -$429,412 16,188,781 -3.5% Rosalind Advisors, Inc. 31 Dec 2025
MYO MYOMO, INC. Common Shares 9.9% $7,527,000 +$48,494 7,603,030 +0.65% Rosalind Advisors, Inc. 31 Dec 2025
KPRX KIORA PHARMACEUTICALS INC Common Shares 9.9% 464,676 0% Rosalind Advisors, Inc. 31 Dec 2025
FENC FENNEC PHARMACEUTICALS INC. Common Shares 9.8% $21,095,731 +$5,145,600 2,746,840 +32% Rosalind Advisors, Inc. 31 Dec 2025
NSPR InspireMD, Inc. Common Shares 9.2% $19,557,045 10,987,104 0% Rosalind Advisors, Inc. 31 Dec 2025
MDWD MediWound Ltd. Common Shares 7% 912,319 0% Rosalind Advisors, Inc. 31 Dec 2025
CLRB Cellectar Biosciences, Inc. Common Shares 5.5% 247,715 -97% Rosalind Advisors, Inc. 31 Dec 2025
TRVI Trevi Therapeutics, Inc. Common Shares 1.2% $6,746,875 1,062,500 Rosalind Advisors, Inc. 13 Feb 2025
OPTN OptiNose, Inc. Common Shares 0% $0 -$3,128,407 0 -100% Rosalind Advisors, Inc. 30 Jun 2025
SPRB SPRUCE BIOSCIENCES, INC. Common shares 0% $0 0 Rosalind Advisors, Inc. 31 Dec 2024

Schedules 13D/G Reported by Rosalind Advisors, Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.